GTG restructures to focus on molecular diagnosis

Genetic Technologies (ASX:GTG) has announced a restructuring project, as well as plans to launch the upgraded version of breast cancer risk test BREVAGen next month. [+]

> Posted in Molecular biology on 15 September, 2014

Calzada, pSivida, GI Dynamics announce board moves

Calzada (ASX:CZD) has announced the resignation of an independent director, while GI Dynamics (ASX:GID) and pSivida (ASX:PVA) have selected new members for their own... [+]

> Posted in Biotechnology on 11 September, 2014

2014 Eureka Prizes announced

The Australian Museum Eureka Prizes last night celebrated 25 years of rewarding outstanding contributions to Australian science.


> Posted in Life sciences on 11 September, 2014

Invion ready to escalate dose in lupus trial

Analysis of safety data from the first two cohorts involved in Invion's (ASX:IVX) trial of INV103 in lupus has given the company the confidence to step up the dose for... [+]

> Posted in Biotechnology on 09 September, 2014

Viralytics CEO, biotech veteran join company board

Former CSL (ASX:CSL) executive Peter Turvey has been named a Viralytics (ASX:VLA) non-executive director, while Viralytics CEO Malcolm McColl will take the role of... [+]

> Posted in Biotechnology on 08 September, 2014

Latest News

Orthocell, Antisense bolster IP portfolios

Orthocell (ASX:OTI) has been granted an Australian patent for its regenerative product Ortho-ATI,... [+]

> Posted in Biotechnology

Prestigious International Biotechnology Symposium coming down under

In a major coup for the biotechnology industry in Australia, the prestigious International... [+]

> Posted in Biotechnology

Nexvet expands veterinary biologics research team

Two former CSL (ASX:CSL) scientists have joined Nexvet's veterinary biologics research centre... [+]

> Posted in Biotechnology

Call for ideas to partner with GSK

GSK is calling for Australian and New Zealand researchers and start-up companies to submit... [+]

> Posted in Health & medical

Potential new treatment for GVHD

A potential new treatment option for bone marrow transplant patients who develop... [+]

> Posted in Life sciences

Click here for your FREE subscription

Lab+Life Scientist: The Magazine

Lab+Life Scientist - the magazine for Australia’s scientific and research leaders and innovators. Click for your FREE subscription